Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Carotid Disease & Stroke

  • 1
    News

    SPRINT: Pill burden affects ability to reach systolic BP control

    October 1, 2018

    CHICAGO – Patients in the SPRINT trial were less likely to meet the intensive treatment goal – systolic blood pressure below 120 mm Hg – if they were taking five or more medications a day.

  • 1
    News

    Impaired kidney function no problem for dabigatran reversal

    April 23, 2018

    ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.

  • 1
    News

    Common infections are potent risk factor for MI, stroke

    April 13, 2018

    ORLANDO – Huge U.K. registry identifies a novel cardiovascular risk factor: hospitalization for UTI or respiratory infection.

  • 1
    Video

    Post-ACS death lowered in ODYSSEY Outcomes 

    March 10, 2018

    ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.

  • 1
    News

    Benefit of dabigatran over warfarin persists in AF patient subgroups undergoing PCI

    December 3, 2017

    ANAHEIM, CALIF. – Dabigatran protected against thromboembolic events with less bleeding regardless of stent type, type of concomitant treatment, or indication for PCI.

  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Style Guide for Authors
  • Subscribe
  • Advertise
  • Copyright © 2000-2022 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement